Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Cardiac Pathways

This article was originally published in The Gray Sheet

Executive Summary

Cardiac Pathways: Arrhythmia Mapping System multiple-electrode catheter is used for the first time on a patient in The Netherlands. The system identified "three different sites responsible for ventricular tachycardias within 73 seconds, compared to three to four hours required by single-point mapping catheters," the company says. The 64-electrode basket catheter, used in conjunction with the company's Cooled Ablation radiofrequency catheter, is "introduced in a collapsed state...to enable its traverse through the arteries" to the left ventricle, where it is "fully deployed" using eight "arms" to map the entire ventricle "within several heartbeats." Cardiac Pathways submitted an investigational device exemption application for the system to FDA in September...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT005172

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel